AbbVie Inc (ABBV)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 4,278,000 5,122,000 5,339,000 5,993,000 4,863,000 6,514,000 8,685,000 7,585,000 11,836,000 13,407,000 12,637,000 12,479,000 11,542,000 7,534,000 6,663,000 5,159,000 4,616,000 7,381,000 6,957,000 8,436,000
Total assets US$ in thousands 135,161,000 143,422,000 141,937,000 148,874,000 134,711,000 136,221,000 135,367,000 134,544,000 138,805,000 141,325,000 143,186,000 143,211,000 146,529,000 148,858,000 147,972,000 150,501,000 150,565,000 149,621,000 149,530,000 91,199,000
ROA 3.17% 3.57% 3.76% 4.03% 3.61% 4.78% 6.42% 5.64% 8.53% 9.49% 8.83% 8.71% 7.88% 5.06% 4.50% 3.43% 3.07% 4.93% 4.65% 9.25%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $4,278,000K ÷ $135,161,000K
= 3.17%

AbbVie Inc's return on assets (ROA) has fluctuated over the period from March 31, 2020, to December 31, 2024.

The ROA started at a relatively high level of 9.25% in March 2020, then decreased to 4.65% by June 2020, and continued to decline to 3.07% by December 2020. This downward trend reversed in the following quarters as the ROA gradually increased to 8.83% by June 2022.

After reaching a peak of 9.49% in September 2022, the ROA experienced some fluctuations but generally stayed above 4% until December 2024. The ROA showed a slight decline in the last quarter, falling to 3.17% by December 31, 2024.

Overall, AbbVie Inc's ROA demonstrates variability over the period under consideration, with both upward and downward trends. It is important for investors and analysts to monitor these changes in ROA to understand how efficiently the company is generating profits from its assets.


See also:

AbbVie Inc Return on Assets (ROA) (Quarterly Data)